Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes  by Breurec, S. et al.
Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in
ﬁve major African towns: high prevalence of Panton–Valentine
leukocidin genes
S. Breurec1, C. Fall1, R. Pouillot2, P. Boisier3, S. Brisse4, F. Diene-Sarr1, S. Djibo3, J. Etienne5, M. C. Fonkoua2,
J. D. Perrier-Gros-Claude6, C. E. Ramarokoto7, F. Randrianirina7, J. M. Thiberge4, S. B. Zriouil8,9, the Working Group on
Staphylococcus aureus infections*, B. Garin1, and F. Laurent5,
1) Institut Pasteur, Dakar, Senegal, 2) Centre Pasteur, Yaounde, Cameroon, 3) CERMES, Niamey, Niger, 4) Institut Pasteur, Paris, 5) University of Lyon,
National Reference Centre for Staphylococci, Lyon, France, 6) Institut Pasteur, Casablanca, Morocco, 7) Institut Pasteur, Antananarivo, Madagascar,
8) Ibn Rochd University Hospital and 9) Hassan II University, Casablanca, Morocco
Abstract
The epidemiology of methicillin-susceptible Staphylococcus aureus (MSSA) in Africa is poorly documented. From January 2007 to March
2008, 555 S. aureus isolates were collected from ﬁve African towns in Cameroon, Madagascar, Morocco, Niger, and Senegal; among
these, 456 unique isolates were susceptible to methicillin. Approximately 50% of the MSSA isolates from each different participating cen-
tre were randomly selected for further molecular analysis. Of the 228 isolates investigated, 132 (58%) belonged to ﬁve major multilocus
sequence typing (MLST) clonal complexes (CCs) (CC1, CC15, CC30, CC121 and CC152) that were not related to any successful
methicillin-resistant S. aureus (MRSA) clones previously identiﬁed in the same study population. The luk-PV genes encoding Panton–
Valentine leukocidin (PVL), present in 130 isolates overall (57%), were highly prevalent in isolates from Cameroon, Niger, and Senegal
(West and Central Africa). This ﬁnding is of major concern, with regard to both a source of severe infections and a potential reservoir
for PVL genes. This overrepresentation of PVL in MSSA could lead to the emergence and spread of successful, highly virulent PVL-posi-
tive MRSA clones, a phenomenon that has already started in Africa.
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Introduction
Staphylococcus aureus is a major human pathogen and the
leading cause of hospital-associated infections. First reported
in 1961 [1], methicillin-resistant S. aureus (MRSA) has
become endemic in hospitals worldwide. In the 1990s, out-
breaks of community-associated MRSA (CA-MRSA) infection
became increasingly frequent [2]. Methicillin-susceptible
S. aureus (MSSA) lineages have been the subject of fewer
molecular studies than MRSA [3], but knowledge of MSSA
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genetic backgrounds and associated virulence factors is
important for understanding the dynamics of the emergence
of hospital-acquired MRSA and CA-MRSA.
It is now established that the population structure of
MSSA is genetically more diverse than that of MRSA, and
that MRSA originated from a limited number of epidemic
MSSA lineages through transfer of the staphylococcal cas-
sette chromosome mec (SCCmec) [3]. This suggests that
some MSSA genetic backgrounds may not provide a stable
genetic environment for SCCmec integration [3]. Few data
on the population structure of MSSA lineages, their rela-
tionship to MRSA lineages and associated virulence factors
are available in Africa as compared with industrialized
countries [4–10], but ongoing surveillance of MSSA lineages
is important to anticipate the emergence of virulent
MRSA.
Here, we report the molecular characterization of MSSA
isolates in ﬁve major African towns, namely Antananarivo
(Madagascar), Casablanca (Morocco, Maghreb), Dakar (Sene-
gal, West Africa), Niamey (Niger, West Africa), and Yaounde
(Cameroon, Central Africa), by means of accessory gene reg-
ulator (agr) typing, multilocus sequence typing (MLST), staph-
ylococcal protein A (spa) typing, and toxin proﬁling.
Antimicrobial susceptibility was also evaluated.
Materials and Methods
Study population
All patients with suspected staphylococcal infection were
pre-included in seven major tertiary-care centres located in
ﬁve major African towns, namely Antananarivo (Madagascar),
Casablanca (Morocco), Niamey (Niger), Dakar (Senegal), and
Yaounde (Cameroon), between January 2007 and March
2008 (January 2007 to June 2007 in Casablanca). Patients
were subsequently included in the study if S. aureus infection
was conﬁrmed. A standardized speciﬁc medical questionnaire
was completed during hospitalization, to collect demographic
data, the medical history over the previous 12 months, the
reason for admission, and the time between admission and
sample collection for culture. If more than one S. aureus iso-
late with the same spa type was recovered from the same
patient, only the ﬁrst was included. Isolates were considered
to be community-acquired if recovered by culture from a
sample obtained within 48 h after admission in a patient
with no risk factors for nosocomial acquisition in the previ-
ous year, namely hospitalization or surgery, use of an
indwelling catheter or a percutaneous device, or frequent
exposure to healthcare facilities for an underlying chronic
disorder. All other isolates were considered to be hospital-
acquired. Owing to the large number of strains collected,
about half of the MSSA isolates from each different partici-
pating centre were randomly selected for further molecular
analysis. The study protocol was approved by local ethics
committees.
Microbiological analysis, DNA extraction, mecA detection,
agr typing, and toxin gene proﬁling
S. aureus identiﬁcation and genomic DNA extraction were
performed as previously described [3]. Isolates were
screened for genes encoding staphylococcal enterotoxins A,
C, D, H, M, P, and R (sea, sec, sed, seh, sem, sep, and ser),
toxic shock syndrome toxin 1 (tst), exfoliative toxins A, B,
and D (eta and etb), Panton–Valentine leukocidin (PVL) (luk-
PV), class F LukM leukocidin (lukM), and b-haemolysin (hlb),
as previously described [11].
Spa typing
Spa sequence typing was performed on S. aureus isolates
with the Ridom Staph Type standard protocol (http://www.
ridom.com/doc/Ridom_spa_sequencing.pdf) and the Ridom
SpaServer, which automatically analyses spa repeats and
assigns spa types (http://spa.server.ridom.de). By application
of the BURP algorithm implemented in Ridom StaphType
software version 1.4 (Ridom GmbH, Wu¨rzburg, Germany),
spa types with more than four repeats were clustered into
different spa clonal complexes (CCs), with the calculated
cost between members of a group being 4 or less.
MLST
The associated MLST CCs were allocated with the Ridom
SpaServer [12], if possible. To conﬁrm the concordance
between the MLST and spa CCs, MLST was performed as
described elsewhere [13] on a set of representative strains
from each spa type found within the ﬁve major spa CCs,
each spa CC including more than 20 strains, and also within
the spa CCs corresponding to three major MRSA CCs
(associated MLST CC5, CC8, and CC88) described else-
where [3,4].
Antimicrobial susceptibility
Susceptibility to penicillin, oxacillin, cefoxitin, gentamicin,
kanamycin, tobramycin, tetracycline, erythromycin, lincomy-
cin, pristinamycin, fosfomycin, fusidic acid, rifampicin, peﬂoxa-
cin, co-trimoxazole and vancomycin was determined by each
participating laboratory, following the guidelines of the French
Society for Microbiology. S. aureus strain ATCC 25923 was
used for quality control. External quality control was ensured
by the French National Antibiotic Reference Centre (Institut
Pasteur, Paris).
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Statistical analysis
Pearson’s chi-square test and Fisher’s exact test were used
as appropriate to test associations between qualitative vari-
ables. Signiﬁcance was assumed at p <0.05.
Results and Discussion
In total, 542 S. aureus-infected patients were included during
the study period. The relatively small size of the sample
reﬂects the clinical situation in Africa, including a lack of rou-
tine bacteriological samples and frequent initiation of antibi-
otic therapy before biological sampling. Six hundred and nine
biological samples were taken, and 555 S. aureus isolates
were collected; among these, 456 unique isolates were sus-
ceptible to methicillin. Sixty-one per cent of isolates were
recovered from male patients. The patients’ mean age was
29.8 years (range 1–84 years; median 26 years, 25th percen-
tile 13 years, 75th percentile 44 years). About half of the
MSSA isolates from each site (228 in total) were randomly
selected for molecular studies. The number of isolates
selected per site is shown in Table 1. The isolates were
mainly associated with skin and soft tissue infections (SSTIs)
and surgical site infections at all the sites except in Dakar,
where all types of infection were noted. The lack of routine
blood culture probably explains the small number of isolates
associated with bacteraemia/septicaemia and osteomyelitis.
The 86 unique MRSA isolates collected simultaneously have
been already described elsewhere [4]. They belonged mainly
to three major clones (deﬁned by their sequence type (ST)
and SCCmec type), namely ST239/241-III (n = 34, 40%), a
well-known pandemic clone, and two atypical clones, ST88-
IV (n = 24, 28%) and ST5-IV (n = 18, 21%). Almost all of the
isolates (94%) belonging to the latter clone were PVL-posi-
tive, suggesting that the spread of MRSA carrying luk-PV
genes is a cause for concern, especially in Dakar and possibly
throughout Africa.
The 228 MSSA isolates belonged to 87 spa types. The
BURP algorithm separated 222 isolates into 16 spa CCs and
19 singletons (groups represented by a single type). Four spa
types (six strains) shorter than ﬁve repeats were excluded
from the clustering. A total of 44 spa types assigned to eight
spa CCs were investigated by MLST, and 16 STs were found.
Each spa CC corresponded to one MLST CC, conﬁrming the
excellent concordance of these typing methods (Table 2)
[12]. More than half of the isolates (n = 132, 58%) belonged
to only ﬁve MLST CCs: CC121 (19%), CC15 (12%), CC1
(9%), CC152 (9%), and CC30 (9%). The remaining isolates
belonged to CC8 (6%), CC5 (4%), and CC88 (3%), as well as
eight spa CCs (13%) with no founder and 19 singletons
(13%) (Tables 2 and S1).
The ﬁve major CCs recovered in our study shared signiﬁ-
cant features (Table 2): (i) an unusually high prevalence of
luk-PV genes encoding PVL; (ii) detection in at least three
participating centres, indicating their wide geographical distri-
bution; (iii) presence in both the hospital and community set-
tings; and (iv) susceptibility to most of the antibiotics tested,
except for penicillin (91% of resistant isolates), tetracycline
(46%), and co-trimoxazole (22%).
The ﬁrst two major CCs—CC121 (agr4, spa type t314 or
related, ST121) and CC15 (agr1, spa type t084 or related,
mainly ST15 (96%))—accounted for 44 (19%) and 27 (12%)
of the 228 isolates, respectively (Table 2). The main toxin
genes were the luk-PV (93%) and sem genes (98%), found in
isolates belonging to ST121, and luk-PV (27%), eta (23%) and
sea (n = 6, 23%) in ST15 isolates. These two clones (each
deﬁned by an ST) shared the following features: (i) they have
already been extensively described as major MSSA clones in
many countries in the Americas, Asia, and Europe [10,14,15],
but have also been found in Algeria, Cape Verde Islands,
TABLE 1. Distribution of 228 methicillin-susceptible Staphylococcus aureus isolates obtained in ﬁve African towns (Antananar-
ivo, Casablanca, Dakar, Niamey, and Yaounde) according to the presence of Panton–Valentine leukocidin (PVL) and the types
of infectiona
Antananarivo Casablanca Dakar Niamey Yaounde Total
N PVL+, n (%) N PVL+, n (%) N PVL+, n (%) N PVL+, n (%) N PVL+, n (%) N PVL+, n (%)
Bacteraemia 0 0 0 0 17 8 (47) 0 0 0 0 17 8 (47)
Myositis 0 0 0 0 25 23 (92) 0 0 0 0 25 23 (92)
Osteomyelitis 2 0 0 0 11 8 (73) 5 3 (60) 1 1 (100) 19 12 (63)
Pulmonary infection 0 0 0 0 6 3 (50) 0 0 0 0 6 3 (50)
Skin and soft tissue infection 24 8 (33) 18 3 (17) 47 34 (72) 13 10 (77) 17 12 (71) 119 67 (56)
Surgical site infection 12 5 (42) 0 0 7 1 (14) 14 7 (50) 3 3 (100) 36 16 (44)
Genitourinary tract infection 2 0 0 0 2 0 0 0 0 0 4 0
Unknown type of infection 0 0 0 0 0 0 0 0 2 1 (50) 2 1 (50)
Total 40 13 (33) 18 3 (17) 115 77 (67) 32 20 (63) 23 17 (74) 228 130 (57)
N, total number of strains isolated.
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Mali, Nigeria, and South Africa [5,8–10]; and (ii) these two
genetic backgrounds have rarely (CC15) or never (CC121)
been identiﬁed in MRSA isolates [3], suggesting that they
may not provide a stable genetic environment for SCCmec
integration.
The third and fourth major CCs—CC1 (agr3, spa type
t127 or related, mainly ST852 (90%)) and CC152 (agr1, spa
type t355 or related, mainly ST152 (75%))—corresponded to
21 (9%) and 20 (9%) isolates, respectively. In ST852, the pre-
dominant toxin genes were seh (84%), luk-PV (63%), and sea
(58%). This clone has rarely been described, with one isolate
having been detected in Germany [16] and two in Mali [5].
However, CC1 is a major worldwide MSSA clonal lineage,
and the putative founder, ST1, which was not found in
our study, is a successful CA-MRSA genetic background [3].
Similarly, ST152 has been associated sporadically with a CA-
MRSA genetic background in several countries throughout
Europe (Denmark, Germany, Austria, and Slovenia) [3], and
at a high frequency with an MSSA background in Mali [5] and
Nigeria [7]. The hlb and luk-PV genes were usually present
(93%). The ﬁfth CC, CC30 (agr3 and spa type t318 or
related), a successful MRSA lineage [3], corresponded to 20
isolates (9%) belonging mainly to ST30 (60%). The luk-PV and
sem genes were found in the vast majority of isolates (92%).
The absence of common genetic backgrounds between
major MSSA and MRSA clones is one important ﬁnding in
this study. Only 7% of MSSA isolates (16 of the 228 isolates)
had a genetic background corresponding to the major MRSA
clones found in the same study population during the same
period [4], namely ST239/241-III, ST88-IV, and ST5-IV. Only
the latter two genetic backgrounds were present in MSSA
and MRSA lineages (Table 2). The best strategy with which
TABLE 2. Molecular characteristics of community-associated methicillin-susceptible Staphylococcus aureus (CA-MSSA) and
hospital-acquired methicillin-susceptible S. aureus (HA-MSSA) isolates obtained in ﬁve African towns (Antananarivo, Casa-
blanca, Dakar, Niamey, and Yaounde)
spa
CCs CC ST
Total
(n) spa types (no.) Toxin genesa (no.)
luk-PV
(%)
Location (no.)
HA-MSSA (n = 159)
CA-MSSA
(n = 69)
314 121 121 44 t314 (37), t317 (1), t4499
(1), t159 (4), t645 (1)
sem (43), luk-PV (41), hlb (5),
sec (1), selr (1)
93 D (19), N (6), A (4), Y (3) D (9), N (1), Y
(2)
084 15 15 26 t084 (25), t346 (1) luk-PV (7), eta (6), sea (6), hlb
(1)
27 D (12), N (4), Y (2), A (1),
D (1)
C (3), A (2), D
(1), Y (1)1403 1 t3733 (1) 0
127 1 852 19 t127 (19) seh (16), luk-PV (12), sea (11),
sec (3), sem (2), hlb (2), tst
(1), selp (1)
63 D (10), C (4), A (1), Y (1),
A (1), C (1)
D (3)
1402 2 t948 (2) sea (2), sec (1), seh (1), sem (1) 0
355 152 152 15 t1299 (2), t1096 (1), t355
(12)
luk-PV (14), hlb (14), sem (2) 93 N (6), D (5) Y(1), A (1),
D (1), A (1)
D (3), D (2)
377 4 t5129 (1), t5047 (1), t4687
(1), t468 (1)
luk-PV (4), hlb (4) 100
1471 1 t5127 (1) luk-PV (1), hlb (1) 100
021 30 30 12 t318 (6), t342 (2), t021
(2), t5134 (1), t3646 (1)
sem (11), luk-PV (11), sea (2),
hlb (1)
92 D (5), Y (1), A (1), N (1),
D (4)
D (3), Y (1), D
(4)
535 4 t433 (4) sea (4), sem (4), luk-PV (4), hlb
(1)
100
1472 4 t665 (4) sem (4), luk-PV (4) 100
064 8 8 11 t064 (3), t008 (2), t451
(2), t301 (1), t1705 (1),
t1476 (1), t4688 (1)
sea (5), hlb (2), selp (2), seh (1),
selr (1), tst (1), luk-PV (1)
9 D (3), N (3), C (1), D (2) D (3), A (1)
1404 2 t1617 (2) selp (2) 0
002 5 5 9 t002 (4), t570 (1), t311
(3), t4681 (1)
sem (9), luk-PV (3), sed (3), selr
(3), sea (2), sec (2), selp (2),
tst (1), hlb (1)
33 Y (3), A (3), N (1), N (1) A (1), D (1)
730 1 t4590 (1) sem (1), selp (1) 0
186 88 88 7 t186 (3), t325 (2), t448 (1)
t786 (1)
hlb (2), sea (1), tst (1) 0 A (3), N (1), D (1), Y (1) A (1)
spa CCs with no foun-
derb
Singleton spa types
shorter than ﬁve repeats
66 luk-PV (28), sem (25), sec (6),
seh (11), hlb (10), sea (7), tst
(4), selp (3), eta (2), selr (1)
42 D (11), A (8), Y (8), N (7),
C (5)
D (12), A (8), C
(5), Y (2)
Total 228 luk-PV (130), sem (104), hlb
(44), sea (40), seh (29), sec
(23), selp (11), eta (8), tst (8),
selr (6), sed (3)
57 D (74), N (30), A (25), Y
(19), C (11)
D (41), A (13), C
(8), Y (6), N (1)
A, Antananarivo; C, Casablanca; D, Dakar; N, Niamey; Y, Yaounde; spa CCs, staphylococcal protein A clonal complexes; CC, multilocus sequence typing clonal complex; ST,
sequence type; eta, exfoliatin A; etb, exfoliatin B; etd, exfoliatin D; hlb, b-haemolysin; lukM, staphylococcal leukocidin; luk-PV, Panton–Valentine leukocidin; se, staphylococcal
enterotoxin; tst, toxic shock syndrome toxin.
aetb, etd, sep, ser and lukM genes were not found in any of the isolates.
bEight spa CCs with no founder (30 isolates), 19 singletons (30 isolates), and six isolates with spa-types shorter than ﬁve repeats.
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to determine whether MRSA clones arise locally via SCCmec
acquisition by successful MSSA clones would have been to
analyse MRSA isolates and a representative MSSA collection
during a period preceding the emergence of MRSA, with the
use of high-resolution genotyping methods. Despite the
absence of such data, our results suggest various hypotheses.
The main MRSA clone, ST239/241-III, a well-known pandemic
clone [3], probably did not originate via the introduction of
an SCCmec element into locally dominant MSSA back-
grounds, but was probably imported from abroad, as previ-
ously described [17]. Although most of the MRSA isolates
with the ST5 genetic background were detected in Dakar,
only one MSSA isolate was obtained there, but this does not
exclude an evolutionary link. It has recently been reported
that geographical spread of MRSA isolates with the ST5
genetic background over long distances is rare in comparison
with SCCmec element acquisition [18]. ST88 MSSA isolates
were detected in Antananarivo (n = 4), Dakar (n = 1), Nia-
mey (n = 1), and Yaounde (n = 1), matching the distribution
of ST88-IV MRSA isolates. This latter clone is an atypical suc-
cessful clone found mainly in Africa, suggesting its emergence
from native MSSA. Further studies based on high-resolution
genotyping methods are needed to investigate the evolution-
ary history of this clone [18]. Finally, the high prevalence of
PVL-positive MSSA isolates belonging to CC152, CC30 and
CC1—genetic backgrounds associated with successful CA-
MRSA [3] and possibly representing a stable genetic environ-
ment for SCCmec integration—could pose a serious public
health threat in future.
The second major ﬁnding in this study is the high preva-
lence and high genetic diversity of PVL-positive isolates; luk-
PV genes were detected in 130 (57%) of the 228 isolates
tested, belonging to 39 (45%) of the 87 spa types and to all
the major STs identiﬁed here (Table 2). Interestingly, a large
proportion of the PVL-positive genetic backgrounds
described worldwide were observed in our study [3,9,10].
The luk-PV genes encoding PVL have been linked in epidemi-
ological studies to deep abscesses, severe necrotizing pneu-
monia, and severe bone and joint infections [19,20], and
recent experimental models support a signiﬁcant pathological
contribution of PVL [21,22]. This pore-forming toxin targets
human immune system cells, such as polymorphonuclear
neutrophils, monocytes, and macrophages [23]. Depending
on the concentration, PVL pores cause cytokine release and
cell death by apoptosis or necrosis, which undoubtedly con-
tributes to the pathogenicity of PVL-producing S. aureus iso-
lates [24]. As the MSSA isolates obtained in the participating
centres, except for Dakar, were mainly associated with SSTIs
(Table 1), infections in which PVL has been strongly impli-
cated [25], a recruitment bias cannot be excluded. Neverthe-
less, our data for Dakar, showing a high prevalence of luk-PV
genes (>47%) regardless of the type of infection, except for
surgical site infections, suggest that PVL-positive isolates are
extensively distributed in Senegal (West Africa). Despite the
different distributions of the types of infection across the
study sites, it is noteworthy that the prevalence of PVL-posi-
tive isolates in SSTIs was signiﬁcantly higher in Dakar (72%),
Niamey (77%) and Yaounde (71%) (West and Central Africa)
than in Antananarivo (Madagascar) (33%) and Casablanca
(Maghreb) (17%) (p <0.01). Furthermore, the high prevalence
of nasal carriage of PVL-positive MSSA described in Cape
Verde [9] and Mali [5] (West Africa) (>35%) contrasts with
the low prevalence reported in industrialized countries (0.5–
1.4%) [26–28]. All of these data suggest that West and Cen-
tral Africa have a particularly high prevalence of PVL-positive
MSSA isolates, although further investigations on S. aureus
from nasal sources are needed to conﬁrm this high preva-
lence. Finally, no signiﬁcant difference in the prevalence of
PVL genes was observed between the hospital and commu-
nity settings (p 0.34). When the prevalence of PVL-positive
isolates in the community is high, these isolates are able to
spread in hospitals [29], particularly in Africa, where the per-
manent presence of friends and relatives in hospitals, and the
transfer of some healthcare responsibilities to these persons,
increases the risk of isolate circulation between the commu-
nity and hospital settings [4].
Even though the reasons for this very high prevalence of
PVL-positive MSSA isolates are currently unclear, its implica-
tions in terms of the evolutionary history of S. aureus in
Africa should be investigated. The luk-PV genes are carried
on mobile genetic elements (prophages), implying that PVL-
positive MSSA isolates may represent a reservoir for PVL
genes. These genes could subsequently be incorporated into
S. aureus lineages through horizontal transfer, either before
or after acquisition of the mecA gene [30]. This is a major
concern. Conditions in Africa that increase the risk of inter-
individual transmission (poor access to healthcare services,
poor hygienic and sanitary conditions, overcrowding, etc.),
combined with the high prevalence of PVL-positive S. aureus
isolates, has the potential to lead to massive emergence and
spread of successful and highly virulent PVL-positive MRSA
clones, a phenomenon that has already been described in
Algeria, Cameroon, Morocco, Nigeria, and Senegal [4,6,8].
In conclusion, this study provides an unique overview of
MSSA clones circulating in seven hospitals in ﬁve major Afri-
can towns. We studied isolates from only one or two cen-
tres in each country, which may not be representative of the
overall situation. However, the healthcare institutions studied
here were among the main tertiary hospitals in each of the
ﬁve countries studied. The high prevalence of luk-PV genes
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among MSSA strains is a major concern, both as a source of
severe infections and as a potential reservoir that could
accelerate the emergence of successful clones that are both
PVL-positive and resistant to methicillin. Moreover, human
mobility may hasten the spread of native African clones, and
thus have a signiﬁcant future impact on S. aureus epidemiol-
ogy in other regions of the world.
Acknowledgements
We thank F. B. Badji and F. B. Dieye (Institut Pasteur, Dakar,
Senegal) and H. Meugnier (National Reference Centre for
Staphylococci, Lyon, France) for their technical help, and all
the clinicians involved in this study. We also thank M. Bes
(National Reference Centre for Staphylococci, Lyon, France)
and C. Bouchiat (Institut Pasteur, Dakar, Senegal) for helpful
discussions, and I. Eronini and D. Young for editorial assis-
tance.
Transparency Declaration
This study was supported by grants from Institut Pasteur
(Grant PTR 197) and by Institut de Veille Sanitaire (InVS,
Saint-Maurice, France), and was performed at institutes
belonging to the Institut Pasteur International Network. All
of the authors declare that they have no conﬂicts of interest.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Table S1. Molecular characteristics of CA-MSSA and
HA-MSSA.
Please note: Wiley-Blackwell are not responsible for the
content or functionality of any supporting materials supplied
by the authors. Any queries (other than missing material)
should be directed to the corresponding author for the article.
References
1. Parker MT, Jevons MP. A survey of methicillin resistance in Staphylo-
coccus aureus. Postgrad Med J 1964; 40: 170–178.
2. Ellis MW, Hospenthal DR, Dooley DP et al. Natural history of com-
munity-acquired methicillin-resistant Staphylococcus aureus coloniza-
tion and infection in soldiers. Clin Infect Dis 2004; 39: 971–979.
3. Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aur-
eus. Infect Genet Evol 2008; 8: 747–763.
4. Breurec S, Zriouil SB, Fall C et al. Epidemiology of methicillin-resis-
tant Staphylococcus aureus lineages in ﬁve major African towns: emer-
gence and spread of atypical clones. Clin Microbiol Infect 2010; doi:
10.1111/j.1469-0691.2010.03219.x [Epub ahead of print]
5. Ruimy R, Maiga A, Armand-Lefevre L et al. The carriage population
of Staphylococcus aureus from Mali is composed of a combination of
pandemic clones and the divergent Panton–Valentine leukocidin-posi-
tive genotype ST152. J Bacteriol 2008; 190: 3962–3968.
6. Ramdani-Bouguessa N, Bes M, Meugnier H et al. Detection of
methicillin-resistant Staphylococcus aureus strains resistant to multi-
ple antibiotics and carrying the Panton–Valentine leukocidin genes
in an Algiers hospital. Antimicrob Agents Chemother 2006; 50: 1083–
1085.
7. Okon KO, Basset P, Uba A et al. Cooccurrence of predominant Pan-
ton–Valentine leukocidin-positive sequence type (ST) 152 and multi-
drug-resistant ST 241 Staphylococcus aureus clones in Nigerian
hospitals. J Clin Microbiol 2009; 47: 3000–3003.
8. Ghebremedhin B, Olugbosi MO, Raji AM et al. Emergence of a com-
munity-associated methicillin-resistant Staphylococcus aureus with
unique resistance proﬁle in Southwest of Nigeria. J Clin Microbiol
2009; 47: 2975–2980.
9. Aires-de-Sousa M, Conceicao T, de Lencastre H. Unusually high prev-
alence of nosocomial Panton–Valentine leukocidin-positive Staphylo-
coccus aureus isolates in Cape Verde Islands. J Clin Microbiol 2006; 44:
3790–3793.
10. Goering RV, Shawar RM, Scangarella NE et al. Molecular epidemiol-
ogy of methicillin-resistant and methicillin-susceptible Staphylococcus
aureus isolates from global clinical trials. J Clin Microbiol 2008; 46:
2842–2847.
11. Jarraud S, Mougel C, Thioulouse J et al. Relationships between Staphy-
lococcus aureus genetic background, virulence factors, agr groups
(alleles), and human disease. Infect Immun 2002; 70: 631–641.
12. Strommenger B, Kettlitz C, Weniger T et al. Assignment of Staphylo-
coccus isolates to groups by spa typing, SmaI macrorestriction
analysis, and multilocus sequence typing. J Clin Microbiol 2006; 44:
2533–2540.
13. Enright MC, Day NP, Davies CE et al. Multilocus sequence typing
for characterization of methicillin-resistant and methicillin-suscepti-
ble clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008–
1015.
14. Deurenberg RH, Beisser PS, Visschers MJ et al. Molecular typing of
methicillin-susceptible Staphylococcus aureus isolates collected in the
Yogyakarta area in Indonesia, 2006. Clin Microbiol Infect 2010; 16: 92–
94.
15. Vorobieva V, Bazhukova T, Hanssen AM et al. Clinical isolates of
Staphylococcus aureus from the Arkhangelsk region, Russia: antimicro-
bial susceptibility, molecular epidemiology, and distribution of Pan-
ton–Valentine leukocidin genes. APMIS 2008; 116: 877–887.
16. Strommenger B, Braulke C, Heuck D et al. spa Typing of Staphylococ-
cus aureus as a frontline tool in epidemiological typing. J Clin Microbiol
2008; 46: 574–581.
17. Harris SR, Feil EJ, Holden MT et al. Evolution of methicillin-resistant
Staphylococcus aureus during hospital transmission and intercontinental
spread. Science 2010; 327: 469–474.
18. Nubel U, Roumagnac P, Feldkamp M et al. Frequent emergence and
limited geographic dispersal of methicillin-resistant Staphylococcus
aureus. Proc Natl Acad Sci USA 2008; 105: 14130–14135.
19. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton–Val-
entine leukocidin-producing Staphylococcus aureus in primary skin
infections and pneumonia. Clin Infect Dis 1999; 29: 1128–1132.
20. Gillet Y, Issartel B, Vanhems P et al. Association between Staphylococ-
cus aureus strains carrying gene for Panton–Valentine leukocidin and
highly lethal necrotising pneumonia in young immunocompetent
patients. Lancet 2002; 359: 753–759.
638 Clinical Microbiology and Infection, Volume 17 Number 4, April 2011 CMI
ª2010 The Authors
Clinical Microbiology and Infection ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 633–639
21. Cremieux AC, Dumitrescu O, Lina G et al. Panton–Valentine leukoci-
din enhances the severity of community-associated methicillin-resis-
tant Staphylococcus aureus rabbit osteomyelitis. PLoS ONE 2009; 4:
7204–7211.
22. Labandeira-Rey M, Couzon F, Boisset S et al. Staphylococcus aureus
Panton–Valentine leukocidin causes necrotizing pneumonia. Science
2007; 315: 1130–1133.
23. Szmigielski S, Sobiczewska E, Prevost G et al. Effect of puriﬁed staph-
ylococcal leukocidal toxins on isolated blood polymorphonuclear leu-
kocytes and peritoneal macrophages in vitro. Zentralbl Bakteriol 1998;
288: 383–394.
24. Genestier AL, Michallet MC, Prevost G et al. Staphylococcus aureus
Panton–Valentine leukocidin directly targets mitochondria and
induces Bax-independent apoptosis of human neutrophils. J Clin Invest
2005; 115: 3117–3127.
25. Del Giudice P, Blanc V, de Rougemont A et al. Primary skin abscesses
are mainly caused by Panton–Valentine leukocidin-positive Staphylo-
coccus aureus strains. Dermatology 2009; 219: 299–302.
26. Prevost G, Couppie P, Prevost P et al. Epidemiological data on Staph-
ylococcus aureus strains producing synergohymenotropic toxins. J Med
Microbiol 1995; 42: 237–245.
27. Kuehnert MJ, Kruszon-Moran D, Hill HA et al. Prevalence of Staphylo-
coccus aureus nasal colonization in the United States, 2001–2002.
J Infect Dis 2006; 193: 172–179.
28. Melles DC, van Leeuwen WB, Boelens HA et al. Panton–Valentine
leukocidin genes in Staphylococcus aureus. Emerg Infect Dis 2006; 12:
1174–1175.
29. Carleton HA, Diep BA, Charlebois ED et al. Community-adapted
methicillin-resistant Staphylococcus aureus: population dynamics of an
expanding community reservoir of MRSA. J Infect Dis 2004; 190:
1730–1738.
30. O’Hara FP, Guex N, Word JM et al. A geographic variant of the
Staphylococcus aureus Panton–Valentine leukocidin toxin and the ori-
gin of community-associated methicillin-resistant Staphylococcus aureus
USA300. J Infect Dis 2008; 197: 187–194.
CMI Breurec et al. MSSA in ﬁve major African towns 639
ª2010 The Authors
Clinical Microbiology and Infection ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 633–639
